An encapsulated drug delivery system for recalcitrant urinary tract infection

Sheyda Labbaf, Harry Horsley, Ming Wei Chang, Eleanor Stride, James Malone-Lee, Mohan Edirisinghe, Jennifer L. Rohn

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

One of the hallmarks of urinary tract infection, a serious global disease, is its tendency to recur. Uropathogenic bacteria can invade cells lining the bladder, where they form longer-term intracellular reservoirs shielded from antibiotics, re-emerging at a later date to initiate flare-ups. In these cases, only lengthy systemic antibiotic treatment can eradicate all the reservoirs. Yet, long courses of antibiotics are not ideal, as they can lead to side effects and an increase in antibiotic resistance. Moreover, most antibiotics lose some potency by the time they reach the bladder, and many cannot permeate cells, so they cannot access intracellular reservoirs. Here, using coaxial electrohydrodynamic forming, we developed novel core-shell capsules containing antibiotics as a prototype for a future product that could be infused directly into the bladder. Gentamicin was encapsulated in a polymeric carrier (polymethylsilsesquioxane) and these capsules killed Enterococcus faecalis, a common chronic uropathogen, in vitro in a dose-responsive, slow-release manner. Capsules containing a fluorescent tracer dye in place of gentamicin penetrated human bladder cells and released their dye cargowith no apparent toxicity, confirming their ability to successfully permeate cells. These results suggest that such antibiotic capsules could prove useful in the treatment of recalcitrant UTI.

LanguageEnglish
JournalJournal of The Royal Society Interface
Volume10
Issue number89
DOIs
Publication statusPublished - 6 Dec 2013

Fingerprint

Antibiotics
Drug Delivery Systems
Urinary Tract Infections
Anti-Bacterial Agents
Capsules
Urinary Bladder
Gentamicins
Coloring Agents
Dyes
Enterococcus faecalis
Electrohydrodynamics
Microbial Drug Resistance
Fluorescent Dyes
Linings
Toxicity
Bacteria
Therapeutics

Keywords

  • Drug delivery
  • Microbiology
  • Urinary tract infection

Cite this

Labbaf, Sheyda ; Horsley, Harry ; Chang, Ming Wei ; Stride, Eleanor ; Malone-Lee, James ; Edirisinghe, Mohan ; Rohn, Jennifer L. / An encapsulated drug delivery system for recalcitrant urinary tract infection. In: Journal of The Royal Society Interface. 2013 ; Vol. 10, No. 89.
@article{c1759b8f8dab497c95f353d419848adf,
title = "An encapsulated drug delivery system for recalcitrant urinary tract infection",
abstract = "One of the hallmarks of urinary tract infection, a serious global disease, is its tendency to recur. Uropathogenic bacteria can invade cells lining the bladder, where they form longer-term intracellular reservoirs shielded from antibiotics, re-emerging at a later date to initiate flare-ups. In these cases, only lengthy systemic antibiotic treatment can eradicate all the reservoirs. Yet, long courses of antibiotics are not ideal, as they can lead to side effects and an increase in antibiotic resistance. Moreover, most antibiotics lose some potency by the time they reach the bladder, and many cannot permeate cells, so they cannot access intracellular reservoirs. Here, using coaxial electrohydrodynamic forming, we developed novel core-shell capsules containing antibiotics as a prototype for a future product that could be infused directly into the bladder. Gentamicin was encapsulated in a polymeric carrier (polymethylsilsesquioxane) and these capsules killed Enterococcus faecalis, a common chronic uropathogen, in vitro in a dose-responsive, slow-release manner. Capsules containing a fluorescent tracer dye in place of gentamicin penetrated human bladder cells and released their dye cargowith no apparent toxicity, confirming their ability to successfully permeate cells. These results suggest that such antibiotic capsules could prove useful in the treatment of recalcitrant UTI.",
keywords = "Drug delivery, Microbiology, Urinary tract infection",
author = "Sheyda Labbaf and Harry Horsley and Chang, {Ming Wei} and Eleanor Stride and James Malone-Lee and Mohan Edirisinghe and Rohn, {Jennifer L.}",
year = "2013",
month = "12",
day = "6",
doi = "10.1098/rsif.2013.0747",
language = "English",
volume = "10",
journal = "Journal of The Royal Society Interface",
issn = "1742-5689",
number = "89",

}

An encapsulated drug delivery system for recalcitrant urinary tract infection. / Labbaf, Sheyda; Horsley, Harry; Chang, Ming Wei; Stride, Eleanor; Malone-Lee, James; Edirisinghe, Mohan; Rohn, Jennifer L.

In: Journal of The Royal Society Interface, Vol. 10, No. 89, 06.12.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An encapsulated drug delivery system for recalcitrant urinary tract infection

AU - Labbaf, Sheyda

AU - Horsley, Harry

AU - Chang, Ming Wei

AU - Stride, Eleanor

AU - Malone-Lee, James

AU - Edirisinghe, Mohan

AU - Rohn, Jennifer L.

PY - 2013/12/6

Y1 - 2013/12/6

N2 - One of the hallmarks of urinary tract infection, a serious global disease, is its tendency to recur. Uropathogenic bacteria can invade cells lining the bladder, where they form longer-term intracellular reservoirs shielded from antibiotics, re-emerging at a later date to initiate flare-ups. In these cases, only lengthy systemic antibiotic treatment can eradicate all the reservoirs. Yet, long courses of antibiotics are not ideal, as they can lead to side effects and an increase in antibiotic resistance. Moreover, most antibiotics lose some potency by the time they reach the bladder, and many cannot permeate cells, so they cannot access intracellular reservoirs. Here, using coaxial electrohydrodynamic forming, we developed novel core-shell capsules containing antibiotics as a prototype for a future product that could be infused directly into the bladder. Gentamicin was encapsulated in a polymeric carrier (polymethylsilsesquioxane) and these capsules killed Enterococcus faecalis, a common chronic uropathogen, in vitro in a dose-responsive, slow-release manner. Capsules containing a fluorescent tracer dye in place of gentamicin penetrated human bladder cells and released their dye cargowith no apparent toxicity, confirming their ability to successfully permeate cells. These results suggest that such antibiotic capsules could prove useful in the treatment of recalcitrant UTI.

AB - One of the hallmarks of urinary tract infection, a serious global disease, is its tendency to recur. Uropathogenic bacteria can invade cells lining the bladder, where they form longer-term intracellular reservoirs shielded from antibiotics, re-emerging at a later date to initiate flare-ups. In these cases, only lengthy systemic antibiotic treatment can eradicate all the reservoirs. Yet, long courses of antibiotics are not ideal, as they can lead to side effects and an increase in antibiotic resistance. Moreover, most antibiotics lose some potency by the time they reach the bladder, and many cannot permeate cells, so they cannot access intracellular reservoirs. Here, using coaxial electrohydrodynamic forming, we developed novel core-shell capsules containing antibiotics as a prototype for a future product that could be infused directly into the bladder. Gentamicin was encapsulated in a polymeric carrier (polymethylsilsesquioxane) and these capsules killed Enterococcus faecalis, a common chronic uropathogen, in vitro in a dose-responsive, slow-release manner. Capsules containing a fluorescent tracer dye in place of gentamicin penetrated human bladder cells and released their dye cargowith no apparent toxicity, confirming their ability to successfully permeate cells. These results suggest that such antibiotic capsules could prove useful in the treatment of recalcitrant UTI.

KW - Drug delivery

KW - Microbiology

KW - Urinary tract infection

UR - http://www.scopus.com/inward/record.url?scp=84896546180&partnerID=8YFLogxK

U2 - 10.1098/rsif.2013.0747

DO - 10.1098/rsif.2013.0747

M3 - Article

VL - 10

JO - Journal of The Royal Society Interface

T2 - Journal of The Royal Society Interface

JF - Journal of The Royal Society Interface

SN - 1742-5689

IS - 89

ER -